Medtronic - About the company
Medtronic is an unfunded company, founded in 2023. It operates as a Provider of an interactive training platform for medtronics diabetes management devices. Medtronic has not raised any funding yet. The company has 255 active competitors, including 31 funded and 4 that have exited. Its top competitors include companies like BeatO, Glooko and Health2Sync.
Company Details
Provider of an interactive training platform for medtronics diabetes management devices. It provides users with step by step training modules that cover various aspects of using the diabetes technology, including continuous glucose monitoring systems and insulin delivery devices.
Key Metrics
Sign up to download Medtronic's company profile
Medtronic's funding and investors
Medtronic has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Medtronic's Competitors and alternates
Top competitors of Medtronic include BeatO, Glooko and Health2Sync. Here is the list of Top 10 competitors of Medtronic, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of a smartphone-enabled glucometer and diabetes management app | $50.8M | 69/100 | ||
2nd | Glooko 2010, Palo Alto (United States), Series F | Glucose meter and mobile app for diabetes management | $201M | 67/100 | |
3rd |  Health2Sync 2013, Taipei (Taiwan), Series C | Provider of an app for tracking blood glucose level | $30.5M | 65/100 | |
4th | January 2017, San Francisco (United States), Series B | AI-powered precision health platform delivering personalized insights and recommendations | $28.3M | 54/100 | |
5th | Tidepool 2012, San Francisco (United States), Seed | Diabetes data management platform empowering accessible, actionable, and meaningful insights | $1.5M | 51/100 | |
6th |  Dr. Diary Co 2017, Seoul (South Korea), Series B | Provider of app for diabetes management | $12.2M | 50/100 | |
7th | LibreLinkUp 2016, Orlando (United States), Unfunded | Provider of diabetes management platform for patients | - | - | 46/100 |
8th | Provider of app for blood glucose management | - | 44/100 | ||
9th |  OneTouch Reveal 2011, Malvern (United States), Unfunded | Provider of mobile based application for diabetes management | - | - | 44/100 |
10th | Gendius 2011, Alderley Edge (United Kingdom), Series A | Mobile app to track and improve outcomes for patients with diabetes | $1.08M | 43/100 | |
275th | Medtronic 2023, Unfunded | Provider of an interactive training platform for medtronics diabetes management devices | - | - | 16/100 |
_1573650474211.webp?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Medtronic's competitors? Click here to see the top ones
Medtronic's Investments and acquisitions
Medtronic has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Medtronic
Explore our recently published companies
- Juno Industries - Ottawa based, Seed company
- Ryan Litfin - Eden Prairie based, 2008 founded, Seed company
- Cigenergy - Shenzhen based, 2014 founded, Funding Raised company
- National Commodity & Derivatives Exchange - Mumbai based, 2003 founded, Series B company
- Raj Petro Specialities - Chennai based, 1997 founded, Acquired company
- Valvoline - Lexington based, 1866 founded, Unfunded company
